Xinhui Chen
Qingdao University(CN)North China University of Technology(CN)Shanghai University of Finance and Economics(CN)Xiamen University(CN)Wuhan University(CN)First Affiliated Hospital of Jinan University(CN)
Publications by Year
Research Areas
interferon and immune responses, Cytokine Signaling Pathways and Interactions, RNA modifications and cancer, Virus-based gene therapy research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas(2021)338 cited
- → An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis(2020)245 cited
- → Investigating interior driving factors and cross-industrial linkages of carbon emission efficiency in China's construction industry: Based on Super-SBM DEA and GVAR model(2019)217 cited
- → Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study(2022)212 cited
- → Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State(2016)81 cited
- → E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing